RT Journal Article
SR Electronic
T1 Spectinomycin in gonorrhoea.
JF The British Journal of Venereal Diseases
JO Br J Vener Dis
FD BMJ Publishing Group Ltd
SP 272
OP 273
DO 10.1136/sti.51.4.272
VO 51
IS 4
A1 Ribeiro, J
A1 Mathieson, S I
YR 1975
UL http://sti.bmj.com/content/51/4/272.abstract
AB Of 104 male and nine female patients with uncomplicated acute gonorrhoea who were treated with spectinomycin (males 2 g., females 4 g.), two patients (one male and one female) were considered to be treatment failures. No conclusions can be drawn from the small numbers of female patients investigated. Of the 104 male patients, 93 were followed for 2 weeks or more, giving a failure rate of 1-1 per cent. The drug was well tolerated. Sensitivity tests were carried out on 44 strains of N. gonorrhoeae; 42 strains were sensitive to 2-5 mug./ml. spectinomycin and all strains were sensitive to 5 mug./ml.